Procurement Summary
Country : USA
Summary : Ongoing Interventional Clinical Trial Study Drugs
Deadline : 13 Jun 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 120696560
Document Ref. No. : NIH-SS-7194601-A
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
Please see attached document
Active Contract Opportunity
Notice ID : NIH-SS-7194601-A
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office: NATIONAL INSTITUTES OF HEALTH OLAO
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
Original Published Date: Jun 10, 2025 12:01 pm EDT
Original Date Offers Due: Jun 13, 2025 12:00 pm EDT
Inactive Policy: 15 days after date offers due
Original Inactive Date: Jun 28, 2025
Initiative: None
Classification
Original Set Aside: Total Small Business Set-Aside (FAR 19.5)
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 339112 - Surgical and Medical Instrument Manufacturing
Place of Performance: Bethesda, MD 20892 USA
Documents
Tender Notice
Atorvastatin-and-Plecebo.docx